Terms: = Liver cancer AND AFP, AFPD, FETA, HPAFP
6604 results:
1. The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
Yang CX; Pan YX; Ye F; Zhu XD; Xue J; Li X; Yuan ZG; Zhang L; Xu L; Chen YJ; Wang NY; Sun HC; Liu XF;
Front Immunol; 2024; 15():1310239. PubMed ID: 38711515
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of microwave ablation with parallel acupuncture guided by ultrasound in treating single hepatocellular carcinoma in high-risk areas: A retrospective analysis of 155 patients.
Liu S; Zhou P; Shen Q; Qian G
J Cancer Res Ther; 2024 Apr; 20(2):547-554. PubMed ID: 38687924
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Utility of Cytokeratins for Accurate Diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
[TBL] [Abstract] [Full Text] [Related]
5. Structural characteristics of alpha-fetoprotein, including N-glycosylation, metal ion and fatty acid binding sites.
Liu K; Wu C; Zhu M; Xu J; Lin B; Lin H; Liu Z; Li M
Commun Biol; 2024 Apr; 7(1):505. PubMed ID: 38678117
[TBL] [Abstract] [Full Text] [Related]
6. Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular Carcinoma.
Koizumi A; Komatsu S; Omiya S; Yano Y; Fujishima Y; Ishida J; Kido M; Gon H; Fukushima K; Urade T; So S; Yoshida T; Arai K; Fujinaka R; Shimura Y; Yanagimoto H; Toyama H; Ueda Y; Kodama Y; Fukumoto T
Anticancer Res; 2024 May; 44(5):2055-2061. PubMed ID: 38677746
[TBL] [Abstract] [Full Text] [Related]
7. Therapeutic Management and Outcomes of Hepatoblastoma in a Pediatric Patient with Mosaic Edwards Syndrome.
Sosnowska-Sienkiewicz P; Kamińska A; Anderko I; Telman-Kołodziejczyk G; Mańkowski P; Januszkiewicz-Lewandowska D
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674397
[TBL] [Abstract] [Full Text] [Related]
8. A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
Zhu W; Zhang Z; Chen J; Chen X; Huang L; Zhang X; Huang X; Ma N; Xu W; Yi X; Lu X; Fu X; Li S; Mo G; Wang Y; Yuan G; Zang M; Li Q; Jiang X; He Y; Wu S; He Y; Li Y; Hou J
Signal Transduct Target Ther; 2024 Apr; 9(1):101. PubMed ID: 38643203
[TBL] [Abstract] [Full Text] [Related]
9. [Fonction de l'ARNnc exosomal HEIH dans le carcinome hépatocellulaire associé au virus de l'hépatite B].
Yu T; Li H; Shen G; Wu Q
Ann Biol Clin (Paris); 2024 Apr; 82(1):93-102. PubMed ID: 38638022
[TBL] [Abstract] [Full Text] [Related]
10. Long noncoding RNA small nucleolar RNA host genes as prognostic molecular biomarkers in hepatocellular carcinoma: A meta-analysis.
Huang M; Zhao Z; Yang L
Cancer Med; 2024 Apr; 13(8):e7200. PubMed ID: 38634194
[TBL] [Abstract] [Full Text] [Related]
11. Alpha-fetoprotein: Past, present, and future.
Yeo YH; Lee YT; Tseng HR; Zhu Y; You S; Agopian VG; Yang JD
Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38619448
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors.
Yang LM; Wang HJ; Li SL; Gan GH; Deng WW; Chang YS; Zhang LF
World J Gastroenterol; 2024 Mar; 30(11):1533-1544. PubMed ID: 38617449
[TBL] [Abstract] [Full Text] [Related]
13. Tyrosine hydroxylase inhibits HCC progression by downregulating TGFβ/Smad signaling.
Liu G; Li M; Zeng Z; Fan Q; Ren X; Wang Z; Sun Y; He Y; Sun L; Deng Y; Liu S; Zhong C; Gao J
Eur J Med Res; 2024 Apr; 29(1):228. PubMed ID: 38610044
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
[TBL] [Abstract] [Full Text] [Related]
15. Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Ohama H; Hiraoka A; Tada T; Hirooka M; Kariyama K; Hatanaka T; Tani J; Takaguchi K; Atsukawa M; Itobayashi E; Nishimura T; Tsuji K; Tajiri K; Ishikawa T; Yasuda S; Toyoda H; Fukunishi S; Ogawa C; Kakizaki S; Shimada N; Naganuma A; Kawata K; Kosaka H; Kuroda H; Matono T; Yata Y; Ochi H; Tada F; Nouso K; Morishita A; Itokawa N; Okubo T; Arai T; Tsutsui A; Nagano T; Yokohama K; Nishikawa H; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kumada T;
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2042. PubMed ID: 38577725
[TBL] [Abstract] [Full Text] [Related]
16. Placental metastasis from maternal NUT carcinoma: diagnostic pitfalls and challenges.
Lai JK; Panasci L; Patey NG; Wang H
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38569728
[TBL] [Abstract] [Full Text] [Related]
17. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
18. The Utility of Serum Alpha-fetoprotein for Monitoring for Relapse of Alpha-fetoprotein-Positive Hepatoblastoma.
Davini M; Hastings C; Feusner J
J Pediatr Hematol Oncol; 2024 May; 46(4):206-210. PubMed ID: 38551915
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic Performance of Epithelial Cell Adhesion Molecule for Early Detection of Hepatocellular Carcinoma Among HCV High-Risk Patients.
Nasser R; Al Haddad M; El-Kassas MM; Metwally FM; El-Mezayen HA; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Mar; 25(3):1045-1052. PubMed ID: 38546087
[TBL] [Abstract] [Full Text] [Related]
20. Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma.
Hou C; Xiong B; Zhou L; Fei Y; Shi C; Zhu X; Xie T; Wu Y
BMC Cancer; 2024 Mar; 24(1):387. PubMed ID: 38539150
[TBL] [Abstract] [Full Text] [Related]
[Next]
